Browse Human Gene Sets

Gene set name:

 
  (Enter full or partial name)

By first letter:

 

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB Human collections]

  • H (hallmark gene sets, 50 gene sets)
  • C1 (positional gene sets, 302 gene sets)
  • C2 (curated gene sets, 7837 gene sets)
    • CGP (chemical and genetic pertubations, 3560 gene sets)
    • CP (canonical pathways, 4277 gene sets)
  • C3 (regulatory gene sets, 3712 gene sets)
    • MIR (microRNA targets, 2598 gene sets)
    • TFT (all transcription factor targets, 1114 gene sets)
      • TFT:GTRD (GTRD transcription factor targets, 504 gene sets)
      • TFT:TFT_LEGACY (legacy transcription factor targets, 610 gene sets)
  • C4 (computational gene sets, 1006 gene sets)
    • 3CA (Curated Cancer Cell Atlas gene sets, 148 gene sets)
    • CGN (cancer gene neighborhoods, 427 gene sets)
    • CM (cancer modules, 431 gene sets)
  • C5 (ontology gene sets, 15849 gene sets)
    • GO (Gene Ontology, 9917 gene sets)
      • GO:BP (GO biological process, 6905 gene sets)
      • GO:CC (GO cellular component, 1094 gene sets)
      • GO:MF (GO molecular function, 1918 gene sets)
    • HPO (Human Phenotype Ontology, 5932 gene sets)
  • C6 (oncogenic gene sets, 189 gene sets)
  • C7 (immunologic gene sets, 5219 gene sets)
    • IMMUNESIGDB (ImmuneSigDB gene sets, 4872 gene sets)
    • VAX (vaccine response gene sets, 347 gene sets)
  • C8 (cell type signature gene sets, 866 gene sets)
  • C9 (computational perturbation signature gene sets, 62 gene sets)

Gene sets starting with O

Click on a gene set name to view its gene set page.

OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN
OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP
OCT1_01
OCT1_02
OCT1_03
OCT1_04
OCT1_05
OCT1_06
OCT1_07
OCT1_B
OCT1_Q5_01
OCT1_Q6
OCT_C
OCT_Q6
ODONNELL_METASTASIS_DN
ODONNELL_METASTASIS_UP
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
ODONNELL_TFRC_TARGETS_DN
ODONNELL_TFRC_TARGETS_UP
OHASHI_AURKA_TARGETS
OHASHI_AURKB_TARGETS
OHGUCHI_LIVER_HNF4A_TARGETS_DN
OHGUCHI_LIVER_HNF4A_TARGETS_UP
OHM_EMBRYONIC_CARCINOMA_DN
OHM_EMBRYONIC_CARCINOMA_UP
OHM_METHYLATED_IN_ADULT_CANCERS
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP
OKAWA_NEUROBLASTOMA_1P36_31_DELETION
OKUMURA_INFLAMMATORY_RESPONSE_LPS
OLF1_01
OLSSON_E2F3_TARGETS_DN
OLSSON_E2F3_TARGETS_UP
ONDER_CDH1_SIGNALING_VIA_CTNNB1
ONDER_CDH1_TARGETS_1_DN
ONDER_CDH1_TARGETS_1_UP
ONDER_CDH1_TARGETS_2_DN
ONDER_CDH1_TARGETS_2_UP
ONDER_CDH1_TARGETS_3_DN
ONDER_CDH1_TARGETS_3_UP
ONGUSAHA_BRCA1_TARGETS_DN
ONGUSAHA_BRCA1_TARGETS_UP
ONGUSAHA_TP53_TARGETS
ONKEN_UVEAL_MELANOMA_DN
ONKEN_UVEAL_MELANOMA_UP
ONO_AML1_TARGETS_DN
ONO_AML1_TARGETS_UP
ONO_FOXP3_TARGETS_DN
ONO_FOXP3_TARGETS_UP
OSADA_ASCL1_TARGETS_DN
OSADA_ASCL1_TARGETS_UP
OSAWA_TNF_TARGETS
OSF2_Q6
OSMAN_BLADDER_CANCER_DN
OSMAN_BLADDER_CANCER_UP
OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN
OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
OUILLETTE_CLL_13Q14_DELETION_DN
OUILLETTE_CLL_13Q14_DELETION_UP
OUYANG_PROSTATE_CANCER_MARKERS
OUYANG_PROSTATE_CANCER_PROGRESSION_DN
OUYANG_PROSTATE_CANCER_PROGRESSION_UP
OVOL3_TARGET_GENES
OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN
OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP
OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN
OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP
OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN
OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP
OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN
OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP
OZANNE_AP1_TARGETS_UP
OZEN_MIR125B1_TARGETS